Abstracts Accepted for Publication 2019
DOI: 10.1136/annrheumdis-2019-eular.6424
|View full text |Cite
|
Sign up to set email alerts
|

Ab1298 safety and Efficacy of Primary Yellow Fever Vaccination in Autoimmune Disease: A Prospective Controlled Study

Abstract: Background:Alive vaccines should be used with caution in autoimmune diseases (AID).1 Objectives:To evaluate prospectively adverse events and efficacy of the Yellow Fever vaccine in patients with AID.Methods:Prospective study, including 190 individuals, 47 with Rheumatoid Arthritis (RA), 36 primary Sjögren’s Syndrome (SS), 48 Ankylosing Spondylitis (AS), 8 Systemic Sclerosis (SSc), 24 Systemic Lupus Erythematosous (SLE), and 29 Healthy Controls (HC). All individuals received 17DD (Biomanguinhos-FIOCRUZ) YF vacc… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles